bms747158
Small moleculeexperimentalImaging agent
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00707499)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- bms747158
- bms747158
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00930631 | Phase 1 | Jun 1, 2009 | Covance, Lantheus Medical Imaging |
| NCT00849108 | Phase 2 | Jan 1, 2009 | Lantheus Medical Imaging |
| NCT00707538 | Phase 1 | Jun 1, 2008 | Lantheus Medical Imaging, University of California, Los Angeles |
| NCT00707499 | Phase 1 | Sep 1, 2007 | Lantheus Medical Imaging, University of California, Los Angeles |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lantheus Medical Imaging | For profit | 4 | 4 | 2 | 2007 |
| University of California, Los Angeles | Academic/Hospital | 2 | 0 | 1 | 2007 |
| Covance | For profit | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1